Menu
Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
Drug discovery – wet AMD and cancer
School of Medicine
Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
@ExonateUK on Twitter
We are incredibly proud to be supporting the 3rd @o2hventures o2H Innovation Conference in Ahmedabad this week. @sunilshah123 @prashantshah Our very own @Catherinebeech will be joining a brilliant lineup of speakers
#o2hCollaborativeInnovation #Biotech #WomenInSTEM #innovation
👀Sight – it’s the sense most people say they fear losing. What if sight-saving medicines could be made into a simpler form, one that would be easier to use? @ExonateUK is teaming up with @JanssenGlobal ⬇️ #JPM20
Thrilled to work with Janssen to progress our new eye drop treatment for retinal vascular diseases #eyedisease #retinopathy @JanssenGlobal @JNJInnovation
Excited to announce today our strategic collaboration with #Janssen Pharmaceuticals to develop eye drop treatments for people living with retinal vascular diseases @jnjinnovation @janssenglobal #eyedisease
Congratulations Sunil Shah.
CEO, o2h Discovery Wins Special Recognition Award by OBN UK Ltd
Sunil Shah, CEO, o2h, Wins Special Recognition Award by OBN UK Ltd
We are absolutely delighted to announce that Sunil Shah, CEO, o2h Discovery, has won the Special Recognition Award at the industry leading OBN Awards ...
o2h.com
Enjoying visiting Sydney and feeling incredibly lucky to have this chance to visit labs and conferences in Australia and New Zealand https://bit.ly/32nmAGX @ExonateUK
New @BioBeatUK report indicates that more than 30% of the UK’s top female BioBusiness talent are from BIA member companies 🎉
Check out the report here👇
https://www.mws-consulting.co.uk/wordpress/wp-content/uploads/2019/11/50-Movers-and-Shakers-in-BioBusiness-2019-FINAL-WEB-041119.pdf
Congratulations to all nominated and to our CEO, Dr Catherine Beech for featuring, in the new report Top 50 Movers and Shakers in UK #BioBusiness 2019,
News & Publications - Miranda Weston-Smith
» Read more about: News & Publications »
www.mws-consulting.co.uk